Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 8, 2025Deka in Medicine

Comparative study of SCFA and butyrate levels in chronic hepatitis versus cirrhosis patients

View Full Paper
Ask AI
Bookmark
Share

Authors

SMSyifa MustikaMFMochammad FachrurrezzaIRIraky Mardya Rakhmadhan

Discussion

Loading...

Member takes

Overview

Comparative study reveals no significant differences in SCFA and butyrate levels in patients with chronic hepatitis or cirrhosis, suggesting metabolic influences.

Key Points

  • SCFA levels did not vary significantly between chronic hepatitis and cirrhosis patients, indicating similar metabolic profiles.
  • The overall mean SCFA level among participants was 9.85 mg/mL, with no significant difference in butyrate levels (p = 0.37).
  • Observational study involved fecal sample analysis and gas chromatography to measure SCFA concentrations from patients.
  • Findings highlight the need for further exploration of factors impacting SCFA synthesis in liver disease management.

Cite This Study

Mustika et al. (2025) studied this question.

synapsesocial.com/papers/68af6bf77567bf4f94fe9484https://doi.org/10.69863/dim.2025.e688
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Relationship between gut microbiota dysbiosis and bile acid in patients with hepatitis B-induced cirrhosis2025 · 6 citations
  2. 2A metagenome-wide association study of gut microbiota in hepatitis B virus-related cirrhosis in northwest China2025 · 2 citations
  3. 3Association of Gut Microbiota‐Derived Short‐Chain Fatty Acids With Persistent Elevated Serum Transaminase Levels in Normal Weight and Obesity: A Pilot Study2025 · 3 citations
  4. 4A study on gut microbiota and short-chain fatty acids in patients with inflammatory bowel disease from northwest Iran2025 · 9 citations
  5. 5The potential of short-chain fatty acids-producing probiotics as a treatment for liver disease: a systematic review2025